US 6,335,159 B1 · Retinoic acid receptor ε(rarε)

Abstract

This invention relates to substantially purified Retinoic Acid Receptor ε (RARε), having the amino acid sequence given in FIG. 1, and to the isolated nucleic acid encoding RARε. In addition, polypeptides comprising, and nucleic acids encoding, the DNA-binding and hormone-binding domain of the receptor are provided. Further, methods of detecting RARε and nucleic acids encoding RARε and its domains are provided.

Claims0

Dependent claims

Claims aren’t available for this document.

Facts

Application

08/003,497Filed 12 Jan 1993

Granted

1 Jan 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07K 16/303
From tumour cells: liver or Pancreas
A61K 47/50
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…: the…
C07K 14/70567
Receptors; Cell surface antigens; Cell surface determinants: nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
C07K 14/723
For hormones: g protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor

Retinoic acid receptor ε(rarε)

Life of this patent

Abstract

Claims0

Retinoic acid receptor ε(rarε)

Life of this patent

Abstract

Claims0